---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-027125"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2021-11-03T23:59:59+00:00"
generated_at: "2026-06-28T14:21:32.179525+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GBS appoints Chairman Steven Boyages as Interim CEO; Harry Simeonidis moves to President APAC

## Summary
- Chairman Steven Boyages, MD PhD, appointed Interim CEO effective Oct 29, 2021; no additional compensation.
- Harry Simeonidis resigned as CEO, President, and Board member; stays as President Asia Pacific, Sales & Marketing.
- Board initiates search for permanent CEO via leading executive search firm.
- No disagreements between Company and Mr. Simeonidis related to operations, policies, or practices.
- Boyages has extensive healthcare executive experience, including 9 years as CEO of Sydney West Area Health Service.

## SEC filing metadata
- accession: 0001493152-21-027125
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2021-11-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315221027125/0001493152-21-027125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315221027125/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-027125
- JSON: https://secwatch.observer/filing/0001493152-21-027125.json
- Plain text: https://secwatch.observer/filing/0001493152-21-027125.txt

## Key facts
- Executive change
  Harry Simeonidis was appointed as President Asia Pacific, Sales and Marketing at INTELLIGENT BIO SOLUTIONS INC..
  - Action: appointed
  - Role: President Asia Pacific, Sales and Marketing
  source text: Harry Simeonidis, who served as CEO and President of the Company, vacated these positions prior to Professor Boyages’ appointment as Interim CEO and was appointed to the position of President Asia Pacific, Sales and Marketing, effective October 29, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315221027125/0001493152-21-027125-index.htm
- Executive change
  Steven Boyages was appointed as Interim Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: the board of directors (the “Board”) of GBS Inc. (the “Company”) appointed Professor Steven Boyages, the Chairman of the Board, to the additional position of Interim Chief Executive Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315221027125/0001493152-21-027125-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.